Congenital Heart Disease, Atrial Fibrillation, and Ischemic Stroke Risk.
作者信息
Fox Christine K, Kamel Hooman
机构信息
Departments of Neurology and Pediatrics University of California San Francisco San Francisco CA.
Clinical and Translational Neuroscience Unit, Feil Family Brain and Mind Research Institute and Department of Neurology, Weill Cornell Medicine New York NY.
出版信息
J Am Heart Assoc. 2024 Sep 3;13(17):e036458. doi: 10.1161/JAHA.124.036458. Epub 2024 Aug 27.
Abstract
摘要
相似文献
1
Congenital Heart Disease, Atrial Fibrillation, and Ischemic Stroke Risk.先天性心脏病、心房颤动与缺血性中风风险
J Am Heart Assoc. 2024 Sep 3;13(17):e036458. doi: 10.1161/JAHA.124.036458. Epub 2024 Aug 27.
2
Ischemic Stroke in Patients With Congenital Heart Disease and Atrial Fibrillation.先天性心脏病合并心房颤动患者的缺血性脑卒中。
J Am Heart Assoc. 2024 Sep 3;13(17):e032813. doi: 10.1161/JAHA.123.032813. Epub 2024 Aug 27.
3
Relationship between device-detected burden and duration of atrial fibrillation and risk of ischemic stroke.设备检测到的负担与心房颤动持续时间和缺血性卒中风险之间的关系。
Heart Rhythm. 2021 Mar;18(3):338-346. doi: 10.1016/j.hrthm.2020.10.017. Epub 2020 Oct 23.
4
Stroke Prevention in Atrial Fibrillation: Looking Forward.心房颤动的卒中预防：展望未来。
Circulation. 2020 Dec 15;142(24):2371-2388. doi: 10.1161/CIRCULATIONAHA.120.049768. Epub 2020 Dec 14.
5
Risk of Ischemic Stroke in Patients With Atrial Fibrillation After Extracranial Hemorrhage.颅内出血后伴心房颤动患者的缺血性脑卒中风险。
Stroke. 2020 Dec;51(12):3592-3599. doi: 10.1161/STROKEAHA.120.029959. Epub 2020 Oct 8.
6
Biomarkers for the detection of covert atrial fibrillation after ischemic stroke: NT-proBNP or BNP?缺血性卒中后隐匿性心房颤动检测的生物标志物：NT-脑钠肽还是脑钠肽？
J Stroke Cerebrovasc Dis. 2025 Jun;34(6):108239. doi: 10.1016/j.jstrokecerebrovasdis.2025.108239. Epub 2025 Feb 1.
7
Temporal Association Between Episodes of Atrial Fibrillation and Risk of Ischemic Stroke.心房颤动发作与缺血性卒中风险的时间关联。
JAMA Cardiol. 2021 Dec 1;6(12):1364-1369. doi: 10.1001/jamacardio.2021.3702.
8
Residual risks of ischaemic stroke and systemic embolism among atrial fibrillation patients with anticoagulation: large-scale real-world data (F-CREATE project).抗凝治疗的心房颤动患者缺血性卒中和全身性栓塞的残余风险：大规模真实世界数据（F-CREATE 项目）。
Heart. 2021 Feb;107(3):217-222. doi: 10.1136/heartjnl-2020-317299. Epub 2020 Aug 14.
9
Small Vessel Disease: Perpetrator or Predictor of Stroke in Patients With Atrial Fibrillation?小血管疾病：心房颤动患者中风的始作俑者还是预测指标？
Stroke. 2021 Jan;52(1):100-102. doi: 10.1161/STROKEAHA.120.032536. Epub 2020 Dec 7.
10
Left Atrial Appendage Occlusion With New Watchman-FLX Device.使用新型Watchman-FLX装置进行左心耳封堵术。
Am J Cardiol. 2021 Sep 1;154:135-137. doi: 10.1016/j.amjcard.2021.04.001. Epub 2021 Jul 27.
引用本文的文献
1
First-Ever Stroke Outcomes in Patients with Atrial Fibrillation: A Retrospective Cross-Sectional Study.心房颤动患者首次卒中的结局：一项回顾性横断面研究。
Medicines (Basel). 2025 Jul 24;12(3):18. doi: 10.3390/medicines12030018.
2
Risk of stroke in patients with congenital heart disease: a systematic review and meta-analysis.先天性心脏病患者的中风风险：系统评价和荟萃分析。
BMC Neurol. 2024 Nov 29;24(1):465. doi: 10.1186/s12883-024-03967-8.
3
Spotlight on Neurocardiology: An Emerging Field Gaining Traction Among Neurologists and Cardiologists.神经心脏病学聚焦：一个在神经科医生和心脏病科医生中逐渐受到关注的新兴领域。
J Am Heart Assoc. 2024 Sep 3;13(17):e038026. doi: 10.1161/JAHA.124.038026. Epub 2024 Aug 27.
本文引用的文献
1
Ischemic Stroke in Patients With Congenital Heart Disease and Atrial Fibrillation.先天性心脏病合并心房颤动患者的缺血性脑卒中。
J Am Heart Assoc. 2024 Sep 3;13(17):e032813. doi: 10.1161/JAHA.123.032813. Epub 2024 Aug 27.
2
Anticoagulation management in adult patients with congenital heart disease: a narrative review.成人先天性心脏病患者的抗凝管理：一项叙述性综述。
Cardiovasc Diagn Ther. 2021 Dec;11(6):1324-1333. doi: 10.21037/cdt-20-631.
3
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC.2020年欧洲心脏病学会（ESC）与欧洲心胸外科学会（EACTS）合作制定的心房颤动诊断和管理指南：欧洲心脏病学会（ESC）心房颤动诊断和管理特别工作组，由ESC欧洲心律协会（EHRA）特别贡献制定。
Eur Heart J. 2021 Feb 1;42(5):373-498. doi: 10.1093/eurheartj/ehaa612.
4
Anticoagulation practices in adults with congenital heart disease and atrial arrhythmias in Switzerland.瑞士先天性心脏病合并房性心律失常成人患者的抗凝治疗实践
Congenit Heart Dis. 2018 Sep;13(5):678-684. doi: 10.1111/chd.12627. Epub 2018 Jul 22.
5
Arrhythmias in congenital heart disease: a position paper of the European Heart Rhythm Association (EHRA), Association for European Paediatric and Congenital Cardiology (AEPC), and the European Society of Cardiology (ESC) Working Group on Grown-up Congenital heart disease, endorsed by HRS, PACES, APHRS, and SOLAECE.先天性心脏病中的心律失常：欧洲心律协会（EHRA）、欧洲儿科和先天性心脏病协会（AEPC）以及欧洲心脏病学会（ESC）成人先天性心脏病工作组的立场文件，得到 HRS、PACES、APHRS 和 SOLAECE 的认可。
Europace. 2018 Nov 1;20(11):1719-1753. doi: 10.1093/europace/eux380.
6
Impact of atrial arrhythmias on outcome in adults with congenital heart disease.心房心律失常对成人先天性心脏病患者结局的影响。
Int J Cardiol. 2017 Dec 1;248:152-154. doi: 10.1016/j.ijcard.2017.06.073.
7
Increasing Prevalence of Atrial Fibrillation and Permanent Atrial Arrhythmias in Congenital Heart Disease.先天性心脏病患者心房颤动和永久性房性心律失常的患病率不断增加。
J Am Coll Cardiol. 2017 Aug 15;70(7):857-865. doi: 10.1016/j.jacc.2017.06.034.
8
Thromboprophylaxis for atrial arrhythmias in congenital heart disease: A multicenter study.先天性心脏病房性心律失常的血栓预防：一项多中心研究。
Int J Cardiol. 2016 Nov 15;223:729-735. doi: 10.1016/j.ijcard.2016.08.223. Epub 2016 Aug 13.
9
Ischemic Stroke Risk in Patients With Atrial Fibrillation and CHA2DS2-VASc Score of 1: Systematic Review and Meta-Analysis.房颤且 CHA2DS2-VASc 评分为 1 分的患者的缺血性卒中风险：系统评价和荟萃分析。
Stroke. 2016 May;47(5):1364-7. doi: 10.1161/STROKEAHA.115.012609. Epub 2016 Mar 29.
10
Atrial Fibrillation and Mechanisms of Stroke: Time for a New Model.心房颤动与卒中机制：建立新模型的时候了。
Stroke. 2016 Mar;47(3):895-900. doi: 10.1161/STROKEAHA.115.012004. Epub 2016 Jan 19.
Zotero 插件